How artificial intelligence, salivary biopsy, and data medicine are transforming dentistry into an early detection system for systemic diseases, redefining the role of the dentist, the governance of health data, and the future of preventive medicine. By Ehab Soltan HoyLunes – For a century, dentistry was perceived, and often practiced, as a reactive and mechanical discipline. The dentist was…
Read More
Beyond the fiber: how artificial intelligence, mechanobiology, and the myokine dialogue are redefining the diagnosis of muscle diseases. By Ehab Soltan HoyLunes — For decades, myopathology was a discipline of static observation. The pathologist, armed with a microscope and classic stains, looked for signs of inflammation, necrosis, or protein deposits in isolated tissue samples. However, in 2026, the paradigm…
Read More
How Spain became the preferred laboratory for multinationals—and why this leadership does not yet translate into industrial power. By Ehab Soltan HoyLunes – Europe is undergoing a silent redefinition of its pharmaceutical ecosystem. The regulatory reform driven by the European Commission, the progressive application of the European Health Technology Assessment (HTA) Regulation, and the consolidation of the scientific…
Read More
How to turn EU regulatory reform into a platform for industrial and clinical leadership from Spanish subsidiaries. By Ehab Soltan HoyLunes – Europe is redefining the rules of the pharmaceutical game. The combination of EU legislative reform, the progressive implementation of the Health Technology Assessment (HTA) Regulation, and the consolidation of the European Medicines Agency’s (EMA) scientific role is…
Read More
From mRNA combination vaccines to targeted therapies for pediatric tumors: the EMA drives a new balance between innovation, clinical benefit, and social responsibility. By Ehab Soltan HoyLunes – From the halls of its Amsterdam headquarters, the European Medicines Agency (EMA) is doing more than just validating molecules; it is redefining the operational framework of European healthcare for the coming decade.…
Read More
When medicine stops asking “how to heal?” and begins questioning “how far to transform?”, the operating room becomes the final frontier of the human condition. By Ehab Soltan HoyLunes – The human body has never been strictly biological; it is identity, symbol, and narrative. For centuries, the medical act was limited to the restoration of homeostasis and functionality: suturing,…
Read More
From selective photothermolysis to AI-guided optical biopsy: how photon engineering is redefining diagnosis, treatment, and clinical ethics in the 21st century. By Ehab Soltan HoyLunes – Innovation and Health Special Historically, dermatology was an eminently visual specialty. For centuries, diagnosis depended on morphology observable to the naked eye, and treatment relied on the mechanical or chemical capacity to alter…
Read More
An analysis of biomedical engineering, computer vision, and industrial strategy at the convergence redefining European oral surgery. By Ehab Soltan HoyLunes – For decades, dental implantology was built upon a combination of manual expertise and a two-dimensional interpretation of anatomy. Surgeons relied on tactile sensitivity and panoramic radiographs to navigate a complex three-dimensional environment. However, we are witnessing the…
Read More
Technical, clinical, and strategic analysis of Artificial Intelligence-assisted embryo selection in the European ecosystem: morphokinetic fundamentals, impact on cumulative pregnancy rates, and regulatory challenges under the ESHRE framework and German legislation. By Ehab Soltan HoyLunes – For decades, embryology was a discipline of “clinical intuition” and artisanal mastery. Specialists observed through the microscope, assessed blastocyst symmetry, and, based on…
Read More
A review of the evolution of surgical treatment, systemic chronicity, and the role of artificial intelligence in precision medicine. By Ehab Soltan HoyLunes — Congenital heart disease (CHD) represents the most frequent structural malformation, with a global prevalence stabilized between “8 and 10 cases per 1,000 live births.” However, the most disruptive data point is not its incidence, but…
Read More